FDA Staff Questions Hologic, Inc.'s 3D Mammogram System; FDA Panel To Consider New System On Friday

WASHINGTON, Sept 22 (Reuters) - Hologic Inc’s (HOLX.O) (HOLX.O) three-dimensional digital mammogram technology appears to help doctors screen for breast cancer but issues remain over some of the company’s data, U.S. health reviewers said in documents released on Wednesday.